help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garnero, P.
Right arrow Articles by Spector, T. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garnero, P.
Right arrow Articles by Spector, T. D.

Journal of Clinical Endocrinology & Metabolism, Vol 81, 140-146, Copyright © 1996 by Endocrine Society


ARTICLES

Genetic influence on bone turnover in postmenopausal twins

P Garnero, NK Arden, G Griffiths, PD Delmas and TD Spector
INSERM U-403, Hopital E. Herriot, Lyon, France.

Postmenopausal bone mass is determined by both peak bone mass and subsequent bone loss. Previous studies have shown that peak bone mass is under genetic influence mediated partly by factors affecting bone formation. The rate of bone loss increases markedly after the menopause, but is highly variable from subject to subject. The aims of this study were to determine whether postmenopausal bone turnover was under genetic control, which should be linked to the genetic influence on the rate of postmenopausal bone loss. A classical twin study was performed that compared the intraclass correlations in monozygotic (MZ) twins with those in dizygotic (DZ) twins, with any difference assumed to be due to genetic factors. Markers of bone formation and resorption were measured in 240 untreated postmenopausal twins, aged 45-69 yr, on the average 12.3 yr (SD, 6.0) postmenopause, including 61 MZ pairs and 59 DZ pairs. The intraclass correlation coefficient of MZ twin pairs, rMZ (95% confidence interval), for 2 specific markers of bone formation, serum osteocalcin and bone-specific alkaline phosphatase, were higher than the corresponding rDZ [0.67 (range, 0.59-0.75) vs. 0.48 (range, 0.35-0.61; P = 0.06) for osteocalcin and 0.53 (range, 0.41- 0.65) vs. 0.21 (range, 0.01-0.41; P = 0.02) for bone-specific alkaline phosphatase]. For serum propeptide of type I collagen, a type I collagen synthesis marker that exhibits only a slight increase after menopause, a high proportion of its variance was explained by genetic factors [rMZ = 0.82 (0.77-0.87), rDZ = 0.33 (0.16-0.50); P < 0.001]. The correlations for bone resorption measured by three distinct urinary markers, total deoxypyridinoline and two cross-linked type I collagen peptides (CrossLaps and NTX), that increase markedly after menopause were higher in MZ than in DZ pairs, but the difference reached significance only for NTX (P = 0.03). For urinary free dexoypyridinoline, a marker reflecting bone collagen degradation that increases moderately after menopause, the proportion of the variance explained by genetic factors was highly significant (P = 0.002). In conclusion, our data indicate that a proportion of the variance in postmenopausal levels of both bone formation and resorption markers are explained by genetic factors, but this contribution was clearly significant only for markers that do not change markedly at the menopause. These data suggest that the contribution of genetic factors to overall postmenopausal bone turnover and possibly bone loss is likely to be small.


This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
I. Alam, Q. Sun, L. Liu, D. L. Koller, Y. Liu, H. J. Edenberg, M. J. Econs, T. Foroud, and C. H. Turner
Genomic expression analysis of rat chromosome 4 for skeletal traits at femoral neck
Physiol Genomics, October 8, 2008; 35(2): 191 - 196.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Garnero, F. Munoz, O. Borel, E. Sornay-Rendu, and P. D. Delmas
Vitamin D Receptor Gene Polymorphisms Are Associated with the Risk of Fractures in Postmenopausal Women, Independently of Bone Mineral Density
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4829 - 4835.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. M. Colin, A. G. Uitterlinden, J. B. J. Meurs, A. P. Bergink, M. Van De Klift, Y. Fang, P. P. Arp, A. Hofman, J. P. T. M. van Leeuwen, and H. A. P. Pols
Interaction between Vitamin D Receptor Genotype and Estrogen Receptor {alpha} Genotype Influences Vertebral Fracture Risk
J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3777 - 3784.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. D. Mitchell, S. A. Cole, R. L. Bauer, S. J. Iturria, E. A. Rodriguez, J. Blangero, J. W. MacCluer, and J. E. Hixson
Genes Influencing Variation in Serum Osteocalcin Concentrations Are Linked to Markers on Chromosomes 16q and 20q
J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1362 - 1366.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
Sibling Pair Linkage and Association Studies between Bone Mineral Density and the Insulin-Like Growth Factor I Gene Locus
J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4467 - 4471.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Gunnes, J. P. Berg, J. Halse, and E. H. Lehmann
Lack of Relationship between Vitamin D Receptor Genotype and Forearm Bone Gain in Healthy Children, Adolescents, and Young Adults
J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 851 - 855.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society